NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Genomma Lab Internacional S.A.B. de C.V (MX: LABB)

 
LABB Technical Analysis
4
As on 29th Aug 2025 LABB STOCK Price closed @ 22.37 and we RECOMMEND Buy for LONG-TERM with Stoploss of 19.59 & Strong Buy for SHORT-TERM with Stoploss of 14.36 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

LABBSTOCK Price

Open 22.32 Change Price %
High 22.72 1 Day -0.01 -0.04
Low 22.20 1 Week 1.09 5.12
Close 22.37 1 Month 1.95 9.55
Volume 2833523 1 Year 8.24 58.32
52 Week High 28.88 | 52 Week Low 12.50
 
MX Mexico Most Active Stocks
AMXL 19.28 -0.36%
WALMEX 55.72 0.40%
CEMEXCPO 16.89 -0.12%
FR 579.43 1.24%
GMEXICOB 122.35 -0.53%
ALFAA 14.01 -1.68%
GFNORTEO 170.70 -0.52%
PV 7.92 %
ORBIA 14.84 4.88%
NEMAKA 3.89 3.73%
 
MX Mexico Top Gainers Stocks
ALEATIC 49.86 141.69%
MKSN 54.86 92.49%
GNW 160.21 57.38%
GNW 160.21 57.38%
IP 1140.88 29.20%
IP 1140.88 29.20%
IP 1140.88 29.20%
IP 1140.88 29.20%
IP 1140.88 29.20%
HBCN 1200.00 28.34%
 
MX Mexico Top Losers Stocks
AGLN 502.53 -25.55%
GOLN 54.50 -17.05%
JKSN 613.50 -14.32%
DAIN 1399.55 -13.16%
KMX 1119.44 -12.95%
KMX 1119.44 -12.95%
GSKN 710.00 -10.24%
AIG 1470.00 -10.09%
AIG 1470.00 -10.09%
FFIV 4890.00 -8.34%
 
 
LABB
Daily Charts
LABB
Intraday Charts
Whats New @
Bazaartrend
LABB
Free Analysis
 
LABB Important Levels Intraday
RESISTANCE23.37
RESISTANCE23.05
RESISTANCE22.85
RESISTANCE22.65
SUPPORT22.09
SUPPORT21.89
SUPPORT21.69
SUPPORT21.37
 
LABB Forecast August 2025
4th UP Forecast28.86
3rd UP Forecast26.78
2nd UP Forecast25.49
1st UP Forecast24.21
1st DOWN Forecast20.53
2nd DOWN Forecast19.25
3rd DOWN Forecast17.96
4th DOWN Forecast15.88
 
LABB Weekly Forecast
4th UP Forecast24.09
3rd UP Forecast23.54
2nd UP Forecast23.20
1st UP Forecast22.86
1st DOWN Forecast21.88
2nd DOWN Forecast21.54
3rd DOWN Forecast21.20
4th DOWN Forecast20.65
 
LABB Forecast2025
4th UP Forecast54.72
3rd UP Forecast44.35
2nd UP Forecast37.93
1st UP Forecast31.52
1st DOWN Forecast13.22
2nd DOWN Forecast6.81
3rd DOWN Forecast0.39
4th DOWN Forecast-9.98
 
 
LABB Other Details
Segment EQ
Market Capital 19388327936.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
LABB Address
LABB
 
LABB Latest News
 
Your Comments and Response on Genomma Lab Internacional S.A.B. de C.V
 
LABB Business Profile
Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico, the United States, and Latin America. It offers skin care products under the Cicatricure, Asepxia, and Teatrical brands; hair care products under the Vanart, Medicasp, Tío Nacho, and Sistema GB brands; razor products under the Groomen brand; hydrating beverage under the Suerox brand; and nutritional products for child under the Novamil brand. The company also provides pain relief products under the Alliviax brand; cough and cold medicines under the Tukol and Next brands; and antibacterial products under the Bufferin, XL-3, and Next-AB brands. In addition, it offers HIV diagnosis product under the OraQuick brand. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico. Address: Av. Antonio Dovalí Jaime #70, Mexico City, DF, Mexico, 01210
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service